Eosinophilic leukemia
Eosinophilic leukemia is a rare form of leukemia characterized by the overproduction of eosinophils, a type of white blood cell. This condition can be classified into two main types: chronic eosinophilic leukemia (CEL) and acute eosinophilic leukemia (AEL). Both types involve the abnormal proliferation of eosinophils in the bone marrow and peripheral blood.
Classification[edit]
Eosinophilic leukemia is classified based on the duration and severity of the disease:
- Chronic Eosinophilic Leukemia (CEL): This type progresses more slowly and is characterized by an increased number of eosinophils in the blood and bone marrow over a prolonged period.
- Acute Eosinophilic Leukemia (AEL): This type progresses rapidly and is marked by a significant increase in immature eosinophils, known as blasts, in the bone marrow and blood.
Symptoms[edit]
The symptoms of eosinophilic leukemia can vary but often include:
- Fatigue
- Fever
- Weight loss
- Night sweats
- Anemia
- Splenomegaly (enlarged spleen)
- Hepatomegaly (enlarged liver)
- Skin rashes
Diagnosis[edit]
Diagnosis of eosinophilic leukemia typically involves:
- Complete blood count (CBC) to check the levels of eosinophils
- Bone marrow biopsy to examine the bone marrow for abnormal cells
- Cytogenetic analysis to identify genetic abnormalities
- Molecular testing to detect specific gene mutations
Treatment[edit]
Treatment options for eosinophilic leukemia may include:
- Chemotherapy
- Targeted therapy
- Stem cell transplant
- Corticosteroids to reduce eosinophil levels
Prognosis[edit]
The prognosis for eosinophilic leukemia varies depending on the type and stage of the disease, as well as the patient's overall health. Chronic eosinophilic leukemia generally has a better prognosis than acute eosinophilic leukemia.
Related Pages[edit]
- Leukemia
- Chronic eosinophilic leukemia
- Acute eosinophilic leukemia
- Eosinophil
- Bone marrow
- White blood cell
- Complete blood count
- Chemotherapy
- Stem cell transplant
Categories[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian